93 related articles for article (PubMed ID: 31382296)
1. New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.
Leclair V; Lundberg IE
Curr Rheumatol Rep; 2018 Mar; 20(4):18. PubMed ID: 29550929
[TBL] [Abstract][Full Text] [Related]
2. Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.
Giannini M; Debrut L; Nespola B; Velten M; Geny B; Sibilia J; Meyer A
Nat Rev Rheumatol; 2024 May; 20(5):311-312. PubMed ID: 38514811
[No Abstract] [Full Text] [Related]
3. Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups.
Khoo T; Lilleker JB; Thong BY; Leclair V; Lamb JA; Chinoy H
Nat Rev Rheumatol; 2024 May; 20(5):313-314. PubMed ID: 38514812
[No Abstract] [Full Text] [Related]
4. Where are we moving in the classification of idiopathic inflammatory myopathies?
Tanboon J; Uruha A; Stenzel W; Nishino I
Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
[TBL] [Abstract][Full Text] [Related]
5. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
[TBL] [Abstract][Full Text] [Related]
6. Immune-Mediated Myopathies.
Goyal NA
Continuum (Minneap Minn); 2019 Dec; 25(6):1564-1585. PubMed ID: 31794460
[TBL] [Abstract][Full Text] [Related]
7. Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy.
Yu Z; Cheng H; Liang Y; Ding T; Yan C; Gao C; Wen H
Front Immunol; 2021; 12():642070. PubMed ID: 33936057
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features and Cutaneous Manifestations of Juvenile and Adult Patients of Dermatomyositis Associated with Myositis-Specific Autoantibodies.
Okiyama N
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33923564
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for sustained remission with stratification by myositis-specific autoantibodies in adult polymyositis/dermatomyositis.
Watanabe E; Gono T; Kuwana M; Terai C
Rheumatology (Oxford); 2020 Mar; 59(3):586-593. PubMed ID: 31410476
[TBL] [Abstract][Full Text] [Related]
11. Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review.
Saygin D; Glaubitz S; Zeng R; Bottai M; de Visser M; Dimachkie MM; Fiorentino D; Gerhardson I; Kuwana M; Miller FW; Needham M; Rider LG; Salem Y; Schlüter S; Shinjo SK; Wang G; Werth VP; Aggarwal R; Lundberg IE
Clin Exp Rheumatol; 2024 Feb; 42(2):403-412. PubMed ID: 38436279
[TBL] [Abstract][Full Text] [Related]
12. Narrative review of autoantibodies in idiopathic inflammatory myopathies.
Liu Y; Zheng Y; Hao H; Yuan Y
Ann Transl Med; 2023 Apr; 11(7):291. PubMed ID: 37090051
[TBL] [Abstract][Full Text] [Related]
13. Classification criteria for the idiopathic inflammatory myopathies.
Targoff IN; Miller FW; Medsger TA; Oddis CV
Curr Opin Rheumatol; 1997 Nov; 9(6):527-35. PubMed ID: 9375282
[TBL] [Abstract][Full Text] [Related]
14. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
15. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
16. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria.
Greco M; García de Yébenes MJ; Alarcón I; Brandy-García AM; Rúa-Figueroa Í; Loza E; Carmona L
Ann Rheum Dis; 2019 Sep; 78(9):1291-1292. PubMed ID: 30910990
[No Abstract] [Full Text] [Related]
18. Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria.
To F; Parker MJS; Ventín-Rodríguez C; Lilleker JB; Chinoy H
Rheumatology (Oxford); 2019 Dec; 58(12):2331-2333. PubMed ID: 31382296
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
